[1] Tan FHP, Azzam G. Drosophila melanogaster: Deciphering Alzheimer’s disease. Malaysian J Med Sci 2017;24:6–20. https://doi.org/10.21315/mjms2016.24.2.2.
[2] Pandey UB, Nichols CD. Human disease models in drosophila melanogaster and the role of the fly in therapeutic drug discovery. Pharmacol Rev 2011;63:411–36. https://doi.org/10.1124/pr.110.003293.
[3] Loscalzo DEHRCJ. Building an Ommatidium One Cell at a Time. Bone 2011;23:1–7. https://doi.org/10.1002/dvdy.23707.Building.
[4] Cutler T, Sarkar A, Moran M, Steffensmeier A, Puli OR, Mancini G, et al. Drosophila eye model to study neuroprotective role of CREB binding protein (CBP) in Alzheimer’s disease. PLoS One 2015;10:1–18. https://doi.org/10.1371/journal.pone.0137691.
[5] Kucherenko MM, Marrone AK, Rishko VM, Yatsenko AS, Klepzig A, Shcherbata HR. Paraffin-Embedded and Frozen Sections of <em>Drosophila</em> Adult Muscles. J Vis Exp 2010. https://doi.org/10.3791/2438.
[6] McGurk L, Berson A, Bonini NM. Drosophila as an in vivo model for human neurodegenerative disease. Genetics 2015;201:377–402. https://doi.org/10.1534/genetics.115.179457.
[7] Lee S, Bang SM, Hong YK, Lee JH, Jeong H, Hwan S. The calcineurin inhibitor , Sarah / Nebula , exacerbates A 42 phenotypes in a Drosophila model of Alzheimer’s disease 2015. https://doi.org/10.1242/dmm.018069.